A COL4A4-G394S Variant and Impaired Collagen IV Trimerization in a Patient with Mild Alport Syndrome

被引:2
作者
Kohler, Jennefer [1 ]
Omachi, Kohei [2 ]
Charu, Vivek [3 ]
Miner, Jeffrey H. [2 ]
Bhalla, Vivek [4 ]
机构
[1] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA USA
[2] Washington Univ, Dept Med, Div Nephrol, Sch Med, 660 S Euclid Ave,CB 8126, St Louis, MO 63110 USA
[3] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA USA
[4] Stanford Sch Med, Dept Med, Div Nephrol, 780 Welch Rd, Stanford, CA 94305 USA
来源
KIDNEY360 | 2022年 / 3卷 / 11期
基金
日本学术振兴会;
关键词
glomerular and tubulointerstitial diseases; Alport syndrome; basic science; collagen; genetics; MUTATIONS; GENE;
D O I
10.34067/KID.0005472022
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Missense variants in COL4A genes are often found in patients with an Alport syndrome-like presentation, but their pathogenicity is not always clear. We encountered a woman with microscopic hematuria and proteinuria at 33 years of age with a diagnosis of thin basement membrane disease who was approaching end stage kidney disease at 59 years of age. We hypothesized that this patient's kidney disease was within the spectrum of Alport syndrome. Methods We used histologic, genetic, and biochemical approaches to investigate the mechanisms of kidney disease. By immunofluorescence, we investigated collagen IV chain composition of the glomerular basement membrane (GBM). We employed targeted sequencing to search for pathogenic variants in COL4A and other relevant genes. We utilized N-and C-terminal split NanoLuciferase assays to determine the effect of a novel COL4A4 variant of uncertain significance (VUS) on collagen IV heterotrimer formation in vitro. We transfected COL4A4 expression constructs with split NanoLuciferase fragment-fused COL4A3 and COL4A5 constructs into human embryonic kidney 293T cells. To assay for a3a4a5(IV) heterotrimer formation and secretion, we measured luminescence in cell lysates and culture supernatants from transfected cells. Results Immunostaining suggested that the collagen a3a4a5(IV) network was present throughout the patient's GBMs. DNA sequencing revealed a novel homozygous VUS: COL4A4 c.1180G.A (p. Gly394Ser). In the C-terminal split luciferase-based a3a4a5(IV) heterotrimer formation assays, luminescence levels for G394S were comparable to WT, but in the N-terminal tag assays, the extracellular luminescence levels for G394S were decreased by approximately 50% compared with WT. Conclusions Our cell-based assay provides a platform to test COL4 VUS and shows that G394S impairs assembly of the a3a4a5(IV) N-terminus and subsequent trimer secretion. These data suggest that the COL4A4-G394S variant is pathogenic and causes an atypical mild form of autosomal recessive Alport syndrome.
引用
收藏
页码:1899 / 1908
页数:10
相关论文
共 50 条
  • [1] Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome
    Koyama, Yuimi
    Suico, Mary Ann
    Owaki, Aimi
    Sato, Ryoichi
    Kuwazuru, Jun
    Kaseda, Shota
    Sannomiya, Yuya
    Horizono, Jun
    Omachi, Kohei
    Horinouchi, Tomoko
    Yamamura, Tomohiko
    Tsuhako, Haruki
    Nozu, Kandai
    Shuto, Tsuyoshi
    Kai, Hirofumi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (09) : 874 - 881
  • [2] The Alport Syndrome COL4A5 Variant Database
    Crockett, David K.
    Pont-Kingdon, Genevieve
    Gedge, Frederick
    Sumner, Kelli
    Seamons, Ryan
    Lyon, Elaine
    HUMAN MUTATION, 2010, 31 (08) : E1652 - E1657
  • [3] Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
    Kamura, Misato
    Yamamura, Tomohiko
    Omachi, Kohei
    Suico, Mary Ann
    Nozu, Kandai
    Kaseda, Shota
    Kuwazuru, Jun
    Shuto, Tsuyoshi
    Iijima, Kazumoto
    Kai, Hirofumi
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (05): : 718 - 726
  • [4] Alport Syndrome With a Rare Collagen Type IV Alpha-4 (COL4A4) Gene Mutation: A Case Report
    Rana, Akshaya
    Tayade, Surekha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [5] Alport syndrome associated with diffuse leiomyomatosis: COL4A5-COL4A6 deletion associated with a mild form of Alport nephropathy
    Mothes, H
    Heidet, L
    Arrondel, C
    Richter, KK
    Thiele, M
    Patzer, L
    Sado, Y
    Gubler, MC
    Antignac, C
    Scheele, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (01) : 70 - 74
  • [6] Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
    Savige, Judy
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (06): : 1239 - 1241
  • [7] Identification of a Novel COL4A4 Variant in Compound-Heterozygous State in a Patient With Alport Syndrome and Histological Findings Similar to Focal Segmental Glomerulosclerosis (FSGS)
    Zhu, Feng
    Li, Wencheng
    Li, Zhenqiong
    Zhu, Hongyan
    Xiong, Jing
    FRONTIERS IN GENETICS, 2019, 9
  • [8] A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers
    Korstanje, Ron
    Caputo, Christina R.
    Doty, Rosalinda A.
    Cook, Susan A.
    Bronson, Roderick T.
    Davisson, Muriel T.
    Miner, Jeffrey H.
    KIDNEY INTERNATIONAL, 2014, 85 (06) : 1461 - 1468
  • [9] A case of mild phenotype Alport syndrome caused by COL4A3 mutations
    Masafumi Kamijo
    Mineaki Kitamura
    Kumiko Muta
    Tadashi Uramatsu
    Yoko Obata
    Kandai Nozu
    Hiroshi Kaito
    Kazumoto Iijima
    Hiroshi Mukae
    Tomoya Nishino
    CEN Case Reports, 2017, 6 (2) : 189 - 193
  • [10] Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome
    Cosgrove, D
    Meehan, DT
    Grunkemeyer, JA
    Kornak, JM
    Sayers, R
    Hunter, WJ
    Samuelson, GC
    GENES & DEVELOPMENT, 1996, 10 (23) : 2981 - 2992